David Colleran - Mar 4, 2022 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role: EVP, General Counsel, Corp Sec
Signature: /s/ David Colleran
Stock symbol: ANIK
Transactions as of: Mar 4, 2022
Transactions value $: -$22,798
Form type: 4
Date filed: 3/7/2022, 07:00 AM
Next filing: Mar 11, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIK	Common Stock	Options Exercise	$0	+2.5K	+100%	$0.00	5K	Mar 4, 2022	Direct	F1
transaction	ANIK	Common Stock	Tax liability	-$22.8K	-734	-14.68%	$31.06	4.27K	Mar 4, 2022	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANIK	Restricted Stock Unit	Options Exercise	$0	-2.5K	-50%	$0.00	2.5K	Mar 4, 2022	Common Stock	2.5K	$0.00	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on March 4, 2020.
F2	Reflects an aggregate of 734 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 4, 2022.
F3	Reflects the closing price of ANIK common stock on March 4, 2022, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
F4	Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 4, 2021.